减重手术与重度肥胖合并非酒精性脂肪性肝病成人心血管结局的关联
这项基于MarketScan商业索赔与就诊数据库(2007年1月1日至2017年12月31日)的大型人群回顾性队列研究,纳入86 964例18至64岁、重度肥胖(BMI≥40)且无减重手术史和心血管疾病史的NAFLD成人,采用逆概率治疗加权平衡基线特征后比较减重手术(Roux-en-Y胃旁路术、袖状胃切除术及其他减重术式)与非手术治疗的CVD风险。结果显示,减重手术与CVD风险降低49%相关(aHR 0.51,95%CI 0.48-0.54),主要复合终点风险降低47%(aHR 0.53,95%CI 0.48-0.59),次要复合终点风险降低50%(aHR 0.50,95%CI 0.46-0.53)。作者认为,与常规非手术治疗相比,减重手术与重度肥胖合并NAFLD患者CVD风险显著降低相关。
要点
- 重度肥胖(BMI≥40)合并NAFLD成人中,减重手术与CVD风险降低49%相关(aHR 0.51,95%CI 0.48-0.54)。
- 主要复合终点(心肌梗死、心力衰竭或缺血性卒中)风险降低47%(aHR 0.53,95%CI 0.48-0.59)。
- 次要复合终点(继发性缺血性心脏事件、短暂性脑缺血发作、继发性脑血管事件、动脉栓塞和血栓形成或动脉粥样硬化)风险降低50%(aHR 0.50,95%CI 0.46-0.53)。
- 手术组1568例发生心血管事件,非手术组7215例,发病率差为4.8/100人年(95%CI 4.5-5.0)。
- 该研究为回顾性队列,结果提示相关性而非因果;作者认为减重手术与CVD风险显著降低相关。
适用人群与场景
- 纳入:18至64岁、有保险的成人,非酒精性脂肪性肝病(NAFLD)合并重度肥胖(体重指数≥40),且NAFLD诊断前无减重手术史和心血管疾病史。
- 场景:基于MarketScan商业索赔与就诊数据库的人群研究,非急诊或ICU床旁场景。
- 排除:NAFLD诊断前有减重手术史或心血管疾病史者。
研究设计与关键结果
- 研究类型:大型人群回顾性队列研究,数据来自MarketScan商业索赔与就诊数据库(2007年1月1日至2017年12月31日),数据分析时间为2020年3月至2021年4月。
- 样本与分组:共86 964例成人(平均[SD]年龄44.3[10.9]岁;59 773例女性[68.7%]),其中30 300例(34.8%)接受减重手术(手术组),56 664例(65.2%)接受非手术治疗(非手术组)。
- 干预与对照:减重手术(Roux-en-Y胃旁路术、袖状胃切除术及其他减重术式)对比非手术治疗;采用逆概率治疗加权平衡基线特征,Cox比例风险回归模型(手术为时变变量)分析关联。
- 主要终点:CVD风险降低49%(aHR 0.51,95%CI 0.48-0.54)。
- 主要复合终点(心肌梗死、心力衰竭或缺血性卒中)风险降低47%(aHR 0.53,95%CI 0.48-0.59)。
- 次要复合终点(继发性缺血性心脏事件、短暂性脑缺血发作、继发性脑血管事件、动脉栓塞和血栓形成或动脉粥样硬化)风险降低50%(aHR 0.50,95%CI 0.46-0.53)。
- 事件数:手术组1568例发生心血管事件,非手术组7215例;发病率差为4.8/100人年(95%CI 4.5-5.0)。
证据类型、等级与局限
- 证据类型:大型人群回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,与常规非手术治疗相比,减重手术与重度肥胖合并NAFLD患者CVD风险显著降低相关。
- 该研究为回顾性队列,结果提示相关性,不能据此在急诊或ICU床旁直接推荐减重手术。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
IMPORTANCE: There are no approved treatments for nonalcoholic fatty liver disease (NAFLD) despite its association with obesity and increased risk of cardiovascular disease (CVD).
OBJECTIVE: To examine the association between bariatric surgery and CVD risk in individuals with severe obesity and NAFLD.
DESIGN, SETTING, AND PARTICIPANTS: This large, population-based retrospective cohort study obtained data from the MarketScan Commercial Claims and Encounters database from January 1, 2007, to December 31, 2017. Participants included insured adults aged 18 to 64 years with NAFLD and severe obesity (body mass index ≥40) without a history of bariatric surgery or CVD before NAFLD diagnosis. Baseline characteristics were balanced between individuals who underwent surgery (surgical group) and those who did not (nonsurgical group) using inverse probability of treatment weighting. Data were analyzed from March 2020 to April 2021.
EXPOSURES: Bariatric surgery (Roux-en-Y gastric bypass, sleeve gastrectomy, and other bariatric procedures) vs nonsurgical care.
MAIN OUTCOMES AND MEASURES: The main outcome was the incidence of cardiovascular events (primary or secondary composite CVD outcomes). The primary composite outcome included myocardial infarction, heart failure, or ischemic stroke, and the secondary composite outcome included secondary ischemic heart events, transient ischemic attack, secondary cerebrovascular events, arterial embolism and thrombosis, or atherosclerosis. Cox proportional hazards regression models with inverse probability treatment weighting were used to examine the associations between bariatric surgery, modeled as time varying, and all outcomes.
RESULTS: The study included 86 964 adults (mean [SD] age, 44.3 [10.9] years; 59 773 women [68.7%]). Of these individuals, 30 300 (34.8%) underwent bariatric surgery and 56 664 (65.2%) received nonsurgical care. All baseline covariates were balanced after applying inverse probability treatment weighting. In the surgical group, 1568 individuals experienced incident cardiovascular events compared with 7215 individuals in the nonsurgical group (incidence rate difference, 4.8 [95% CI, 4.5-5.0] per 100 person-years). At the end of the study, bariatric surgery was associated with a 49% lower risk of CVD (adjusted hazard ratio [aHR], 0.51; 95% CI, 0.48-0.54) compared with nonsurgical care. The risk of primary composite CVD outcomes was reduced by 47% (aHR, 0.53 [95% CI, 0.48-0.59), and the risk of secondary composite CVD outcomes decreased by 50% (aHR, 0.50; 95% CI, 0.46-0.53) in individuals with vs without surgery.
CONCLUSIONS AND RELEVANCE: Results of this study suggest that, compared with nonsurgical care, bariatric surgery was associated with significant reduction in CVD risk in individuals with severe obesity and NAFLD.
参考来源
- Elsaid MI, Li Y, Bridges JFP, et al. Association of Bariatric Surgery With Cardiovascular Outcomes in Adults With Severe Obesity and Nonalcoholic Fatty Liver Disease. JAMA Netw Open. 2022. PMID: 36205997. doi:10.1001/jamanetworkopen.2022.35003
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。